Dihydrotestosterone

The Only Taiwanese Company to win the World Food Innovation Awards, TCI is Leading the Upcycling Sustainability in Biotech Industry

Retrieved on: 
Wednesday, June 14, 2023
Advanced glycation end-product, DSM, Food, Rutin, TCI, LEED, Hair, Glycation, Cell proliferation, DHT, Dole plc, Fibroblast, Carbon, CDMO, Dihydrotestosterone, ALDI, Dietary supplement

TAIPEI, June 14, 2023 /PRNewswire/ -- The 2023 World Food Innovation Awards recently announced the list of global winners.

Key Points: 
  • TAIPEI, June 14, 2023 /PRNewswire/ -- The 2023 World Food Innovation Awards recently announced the list of global winners.
  • Two natural health ingredients were recognized as Finalists, which included Banana Flower Stamens Extract, and Soba!
  • The World Food Innovation Awards, jointly organized by FoodBev Media and IFE, is known as the "Global Food Industry Annual Innovation Trendsetter" and the "Oscars of the Global Food Industry," with over 2,500 companies competing for the awards every year.
  • The finalists of the 2023 World Food Innovation Awards are global leaders in the field of food innovation, such as DSM, Dole Food Company, and food retail leader ALDI.

The Only Taiwanese Company to win the World Food Innovation Awards, TCI is Leading the Upcycling Sustainability in Biotech Industry

Retrieved on: 
Wednesday, June 14, 2023
Advanced glycation end-product, DSM, Food, Rutin, TCI, LEED, Hair, Glycation, Cell proliferation, DHT, Dole plc, Fibroblast, Carbon, CDMO, Dihydrotestosterone, ALDI, Dietary supplement

TAIPEI, June 14, 2023 /PRNewswire/ -- The 2023 World Food Innovation Awards recently announced the list of global winners.

Key Points: 
  • TAIPEI, June 14, 2023 /PRNewswire/ -- The 2023 World Food Innovation Awards recently announced the list of global winners.
  • Two natural health ingredients were recognized as Finalists, which included Banana Flower Stamens Extract, and Soba!
  • The World Food Innovation Awards, jointly organized by FoodBev Media and IFE, is known as the "Global Food Industry Annual Innovation Trendsetter" and the "Oscars of the Global Food Industry," with over 2,500 companies competing for the awards every year.
  • The finalists of the 2023 World Food Innovation Awards are global leaders in the field of food innovation, such as DSM, Dole Food Company, and food retail leader ALDI.

Kintor Pharma's KX-826 and GT20029 for Treatment of Androgenetic Alopecia (AGA) and Acne Presented at AAD 2023

Retrieved on: 
Tuesday, March 21, 2023
PROTAC, Male, Hair, Androgen, University, Ars, New York University Grossman School of Medicine, Topical medication, Clinical trial, Pediatric Dermatology, DHT, Emerging, New York University, Research, Gene expression, Inflammation, Chimera, FAAD, Female, TAHC, Gland, HKEX, AGA, Miniaturization, AAD, BID, Growth, Pattern hair loss, Mall of America, Role, Phase, AR, University of Texas System, Birth control, Pharmaceutical industry, Vaccine, Dermatology, Acne, Dihydrotestosterone, Medicine

SUZHOU, China, March 21, 2023 /PRNewswire/ -- The 2023 Annual Meeting of American Academy of Dermatology Association (AAD 2023) was held from 17 to 21 March 2023 in New Orleans, Louisiana, United States.

Key Points: 
  • SUZHOU, China, March 21, 2023 /PRNewswire/ -- The 2023 Annual Meeting of American Academy of Dermatology Association (AAD 2023) was held from 17 to 21 March 2023 in New Orleans, Louisiana, United States.
  • Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939)'s self-developed and potential first-in-class topical drug candidates pyrilutamide (KX-826) and GT20029 have attracted a lot of attention at the meeting, demonstrating the company's innovative capabilities and the therapeutic potential of its androgenetic alopecia (AGA) and acne pipelines.
  • Dr. Adelaide Hebert said that androgens and androgen receptors would play a key role in acne pathogenesis and represent important treatment targets.
  • GT20029's Phase I clinical trials for treatment of AGA and acne in China and the US have been completed.

GIDDY LAUNCHES LINE OF CLEAN-LABEL SEXUAL HEALTH VITAMINS: GIDDY + HEALTH

Retrieved on: 
Wednesday, June 15, 2022
Erectile dysfunction, Prostate, Pygeum, Menopause, Flash, FDA, Health minister, Cognition, GMP, Inflammation, Anxiety, Female, Mineral, View, Testosterone, Libido, Zinc, DIM, Vitamin, PSA, Urination, Man, Nutrient, Absorption, Giddy, Prostate-specific antigen, Actaea racemosa, Life, DHT, Serenoa, Independent medical review, Multimedia, Male, Woman, BPH, Dietary supplement, Medicinal plants, Dihydrotestosterone

AUSTIN, Texas, June 15, 2022 /PRNewswire/ -- Giddy, the world's largest sexual health platform, today announces the launch of Giddy + Health, a new line of clean-label vitamins specially formulated to support sexual health. The doctor reviewed line was built around rigorous scientific research to aid in sexual wellbeing including libido, men's prostate, menopause, and overall health. The microbeads inside the vegetarian capsules provide sustained release, which tends to improve absorption and help maintain optimal blood nutrient levels over time.

Key Points: 
  • Doctor Reviewed And Research-Proven With Vitamins, Minerals And Specialty Nutrients To Boost Libido, Support Hormonal Changes, And Overall Sexual Wellbeing
    AUSTIN, Texas, June 15, 2022 /PRNewswire/ -- Giddy , the world's largest sexual health platform, today announces the launch of Giddy + Health , a new line of clean-label vitamins specially formulated to support sexual health.
  • The doctor reviewed line was built around rigorous scientific research to aid in sexual wellbeing including libido, men's prostate, menopause, and overall health.
  • The Giddy + Health vitamin line includes:
    Male Libido: Boosts vitality and performance, raises testosterone levels, increases blood flow and supports erectile dysfunction.
  • About Giddy: Illuminating sexual wellbeing for all, Giddy is the world's largest sexual health resource.

REVIAN® RED System, Among the Best Hair-Loss Treatments According to Doctors

Retrieved on: 
Monday, December 20, 2021
Nutrient, Skin, Nitric oxide, Disorder, FDA, Oxygen, Hair follicle, Light, Hair, LED, Technology, Hair loss, Method, Compliance, DHT, Movement, Inflammation, Dihydrotestosterone, Cell, VP, Mount Sinai Hospital, Cosmetic, LLLT, Woman, Man, Associate, Expert, Patient, LLC, Scalp, Freedom, Cosmetics, Petroleum jelly, Dermatology, New York (magazine)

The doctors and dermatologists interviewed for this story all agreed that hair loss can be slowed, stopped, or even reversed if the underlying problems are addressed.

Key Points: 
  • The doctors and dermatologists interviewed for this story all agreed that hair loss can be slowed, stopped, or even reversed if the underlying problems are addressed.
  • "The cap delivers precisely engineered red light to the scalp, which enhances circulation to the hair follicles.
  • The REVIAN RED System consists of a lightweight rechargeable cordless cap controlled by a user-friendly mobile app designed to control treatments, provide treatment feedback, and keep users on track.
  • REVIAN is an aesthetic medical technology innovator dedicated to stimulating the body's natural processes to rejuvenate hair and skin with light.

New discovery: Banana beats insomnia and anti-anxiety, approved by the US FDA

Retrieved on: 
Tuesday, November 2, 2021
Serotonin, NDI, Depression, Dihydrotestosterone, Research, TCI, Geneva, Anxiety, FDA, Benign prostatic hyperplasia, Banana Peel, Food, Melatonin, Male, Human body, Gold, Insomnia, Gene expression, Vaccine

The TCI in Taiwan announced that its "Banana Peel, Banana Stamen" has received the FDA's new dietary supplement ingredient NDI safety response, and approved for listing on the US market.

Key Points: 
  • The TCI in Taiwan announced that its "Banana Peel, Banana Stamen" has received the FDA's new dietary supplement ingredient NDI safety response, and approved for listing on the US market.
  • TCI's original patented "Banana Peel Ultrasonic Cold Extraction", the happy banana extracted from banana peel, has similar ingredients to the melancholic drug Prozac, which can significantly improve stress, anxiety and insomnia.
  • The animal study showed that orally administered banana peel extracts were found to have anti-anxiety and depression functions in behavioral activity monitoring.
  • In addition, Happy Angel mainly uses banana stamens, a by-product of bananas, whose extract can prevent prostate enlargement.

Sun Pharma Announces Availability of WINLEVI® (clascoterone) cream 1% in the U.S. for Topical Treatment of Acne Vulgaris

Retrieved on: 
Monday, November 1, 2021
Safety, Woman, JAMA Dermatology, Isotretinoin, MD, Dihydrotestosterone, Lipid, Dermatology, Research, Stinger, Sun Pharma, Veni, vidi, vici, Association, Edema, Androgen, Patient, Hormone, FDA, View, Acne, Itch, Food, CEO, NSE, Clascoterone, Risk, Review, BSE, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, DHT, IGA, MedChemComm, Company, Journal of the American Academy of Dermatology, Gynecomastia, Skin, Investment, Inflammation, Man, Exocrine gland, Cell, Multimedia, Female, Testosterone, American Academy, Erythema, Reuters, Pharmaceutical industry, Sulfur, Birth control, Generic drug, Cosmetics, Medical device

A first-in-class topical androgen receptor inhibitor, WINLEVI was approved by the U.S. Food and Drug Administration (FDA) in August 2020 for the topical treatment of acne vulgaris in patients 12 years of age and older.

Key Points: 
  • A first-in-class topical androgen receptor inhibitor, WINLEVI was approved by the U.S. Food and Drug Administration (FDA) in August 2020 for the topical treatment of acne vulgaris in patients 12 years of age and older.
  • WINLEVI is approved for the topical treatment of acne vulgaris in people aged 12 and older.
  • Each gram of WINLEVI contains 10 mg of clascoterone in a white to almost white cream.
  • Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials.

OliX Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for Investigational Hair Loss Therapeutic, OLX104C

Retrieved on: 
Thursday, August 12, 2021
AMD, KOSDAQ, United States Patent and Trademark Office, RNA, Hair loss, Blood, USPTO, Man, Sexual dysfunction, Male, RNA interference, Disorder, Dihydrotestosterone, Company, Idiopathic pulmonary fibrosis, DHT, Patent, Disease, Hair, Neuropathic pain, GLOBE, IPF, Korea, Hypertrophic scar, Technology, Testosterone, Institute of Liver and Biliary Sciences, Therapy, Vaccine

The patent covers OliXs proprietary technology, which reduces the expression of the androgen receptor and suppresses the hair loss process.

Key Points: 
  • The patent covers OliXs proprietary technology, which reduces the expression of the androgen receptor and suppresses the hair loss process.
  • Existing hair loss treatments are usually accompanied by systemic side effects, such as sexual dysfunction and discomfort due to frequent administration.
  • OLX104C is a long-lasting topical therapeutic that can potentially minimize systemic side effects as it is rapidly degraded upon exposure to blood.
  • We look forward to advancing development of OLX104C as quickly as possible given the millions of people who are affected by hair loss.

OliX Pharmaceuticals Announces Results from Preclinical Study of Hair Loss Therapeutic Candidate

Retrieved on: 
Wednesday, February 10, 2021
Organ systems, Branches of biology, Chemical compounds, Human hair, Androstanes, GABAA receptor positive allosteric modulators, Hair diseases, Pattern hair loss, Dihydrotestosterone, RNA interference, Testosterone, Human hair growth

(KOSDAQ: 226950), a leading developer of RNAi therapeutics, announced that it has demonstrated efficacy in a preclinical study of OLX104C, an investigational RNAi therapeutic in development for androgenic alopecia, also known as hair loss.

Key Points: 
  • (KOSDAQ: 226950), a leading developer of RNAi therapeutics, announced that it has demonstrated efficacy in a preclinical study of OLX104C, an investigational RNAi therapeutic in development for androgenic alopecia, also known as hair loss.
  • In the study, OLX104C was administered topically to a mouse model with suppressed hair growth (Dihydrotestosterone, DHT administered mouse).
  • The study evaluated the percentage of hair regrowth and duration of knockdown of the target protein, AR, following a single injection.
  • We are advancing a novel and potentially durable approach to treating hair loss with large market potential, said Dong Ki Lee, Ph.D., founder and chief executive officer of OliX Pharmaceuticals.

New Survey by ThickTails Among Women Reveals the Extent of Hair Loss During the Menopause

Retrieved on: 
Friday, July 5, 2019
Hormones, Endocrine system, Organ systems, Alcohols, Androstanes, GABAA receptor positive allosteric modulators, Ketones, Sex hormones, Testosterone, Dihydrotestosterone, Menopause, Estrogen

This is congruent with previous medical studies that have shown that during menopause, a woman's estrogen levels fall and the body has a greater presence of testosterone.

Key Points: 
  • This is congruent with previous medical studies that have shown that during menopause, a woman's estrogen levels fall and the body has a greater presence of testosterone.
  • In turn, dihydrotestosterone (DHT) attaches to hair receptors, which causes the hair to get thinner and fall out.
  • ThickTails has created a free booklet for women concerned that their hair is at risk from hormonal changes due to menopause and how to protect themselves.
  • ThickTails is the world's leading female anti-DHT hair growth program designed to protect your hair from hormonal imbalances caused by menopause, stress and childbirth, leaving you with fuller, thicker, healthier hair with less breakage, more volume and less grey.